Adaptive Biotechnologies Corpor (ADPT) Financials
ADPT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 661.1 million | 352.9 million |
| 2023-09-30 | 717.7 million | 356.0 million |
| 2023-06-30 | 764.5 million | 368.6 million |
| 2023-03-31 | 791.5 million | 367.5 million |
ADPT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -28.2 million | 15.6 million |
| 2023-09-30 | -49.5 million | 15.3 million |
| 2023-06-30 | -27.3 million | 17.3 million |
| 2023-03-31 | -62.1 million | 14.7 million |
ADPT Net Income
No data available :(
ADPT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 346.4 million | - | 98.8 million |
| 2023-09-30 | 371.1 million | - | 101.3 million |
| 2023-06-30 | 417.2 million | - | 103.5 million |
| 2023-03-31 | 440.7 million | - | 105.8 million |
ADPT Shares Outstanding
ADPT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 1.3 million | 23.8 million | 20.7 million | 21.9 million |
| 2023-09-30 | 2.8 million | 28.5 million | 20.1 million | 20.5 million |
| 2023-06-30 | 3.7 million | 32.2 million | 22.3 million | 23.9 million |
| 2023-03-31 | 2.9 million | 32.6 million | 20.8 million | 22.3 million |
ADPT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 45.8 million | 25.0 million |
| 2023-09-30 | 37.9 million | 19.3 million |
| 2023-06-30 | 48.9 million | 17.9 million |
| 2023-03-31 | 37.6 million | 18.7 million |
ADPT
Price: $2.93
52 week price:
Earnings Per Share: -1.56 USD
P/E Ratio: -2.68
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.2 million
Market Capitalization: 422.2 million